» Articles » PMID: 1820979

Androgen Increases Androgen Receptor Protein While Decreasing Receptor MRNA in LNCaP Cells

Overview
Date 1991 Apr 1
PMID 1820979
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

We have examined the effect of androgen treatment on androgen receptor mRNA and protein expression in the LNCaP human prostate carcinoma cell line. Incubation with androgen caused a decrease in cellular androgen receptor mRNA content that was concentration and time dependent. Maximal suppression to approximately 35% of control level was observed after 49 h of exposure to androgen. By contrast, incubation of LNCaP cells with androgen resulted in a 2-fold increase in the cellular content of androgen receptor protein at 24 h. At 49 h androgen receptor protein increased 30% as assayed by immunoblots and 79% as assayed by ligand binding. These results suggest that ligand-induced changes in androgen receptor stability and/or the translational efficiency of androgen receptor mRNA account for the phenomenon of androgen receptor upregulation observed in cultured LNCaP cells. Furthermore, the suppression of androgen mRNA and protein that is caused by prolonged incubation with androgen is incomplete and is reversible upon removal of ligand.

Citing Articles

Independent effects of testosterone, estradiol, and sex chromosomes on gene expression in immune cells of trans- and cisgender individuals.

Harris R, Whitfield T, Blanton L, Skaletsky H, Blumen K, Hyland P bioRxiv. 2024; .

PMID: 39416170 PMC: 11482753. DOI: 10.1101/2024.10.08.617275.


Mechanistic insights into steroid hormone-mediated regulation of the androgen receptor gene.

Gillen A, Hunter I, Ullner E, McEwan I PLoS One. 2024; 19(8):e0304183.

PMID: 39088439 PMC: 11293711. DOI: 10.1371/journal.pone.0304183.


Therapeutic Potential of Bipolar Androgen Therapy for Castration-Resistant Prostate Cancer: In Vitro and In Vivo Studies.

Yu J, Lim J, Song W Biomedicines. 2024; 12(1).

PMID: 38255286 PMC: 10813541. DOI: 10.3390/biomedicines12010181.


Antiandrogenic Effects of a Polyphenol in through Inhibition of Androgen Synthetic Pathway and Downregulation of Androgen Receptor in Prostate Cancer Cell Lines.

Kudo Y, Endo S, Tanio M, Saka T, Himura R, Abe N Int J Mol Sci. 2022; 23(22).

PMID: 36430833 PMC: 9696374. DOI: 10.3390/ijms232214356.


Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis.

Gu Y, Xue M, Wang Q, Hong X, Wang X, Zhou F Int J Mol Sci. 2021; 22(24).

PMID: 34948018 PMC: 8704202. DOI: 10.3390/ijms222413222.